Market Research NewsNews

Global Seasonal Affective Disorder Market – Industry Trends, Growth Rate, Forecast Analysis by Manufacturers Janssen Pharmaceuticals, Inc., Pfizer Inc., Merck & Co., Inc., Glaxo Smith Kline plc. and Application to 2024

New report “Global Seasonal Affective Disorder Market“ accounted to USD 520.0 million in 2016 growing at a CAGR of 4.5% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast by 2024.

Global Seasonal Affective Disorder Market report offers a detailed Outlook and future prospects of the Seasonal Affective Disorder Industry with analysis of major players that helps Industry experts, analysts and business decision makers to decide their business strategies and achieve proposed business aims.

Seasonal affective disorder (SAD) is a type of depression or disorder which is related to changes in seasons. SAD frequently happens due to reducing light exposure to sunlight and occurs during a certain time of the year. Women are mostly affected with SAD who aged between 15 to 55 years.

This Report Contains:

No of Pages: 350

No of Figures: 60

No of Tables: 220

Data Bridge Market Research published a research report on “Seasonal Affective Disorder Market Research Report- Forecast 2024” Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2024.

Scope of the report

The report shields the development activities in the seasonal affective disorder Market which includes the status of marketing channels available, and an analysis of the regional export and import. It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments. This will benefit the report’s users, that evaluates their position in the market as well as create effective strategies in the near future.

Get Sample copy of Report Visit @-:

Seasonal Affective Disorder Top Companies: 

Janssen Pharmaceuticals, Inc.,

Pfizer Inc.,

Merck & Co., Inc.,

GlaxoSmithKline plc.,


Eli Lilly and Company,


  1. Hoffmann-La Roche Ltd.,

Henry Schein, Inc.

Among Others

Major Market Drivers and Restraints:

  • Rise in geriatric population
  • Increasing awareness among the people
  • Favorable reimbursement scenario
  • Change in lifestyle
  • Growing market for generic drugs

View Detail TOC of Global Seasonal Affective Disorder Market report Visit @

Segmentation of Global Seasonal Affective Disorder Market

Global Seasonal Affective Disorder Market  Type (Fall and Winter SAD, Spring and Summer SAD, Others), Diagnosis (Physical Exams, Lab Tests, Psychological Evaluation), Treatment (Phototherapy, Medications, Psychotherapy, Counseling), End User, Distribution Channel, Geography- Industry Trends and Forecast to 2024

Competitive Analysis: Global Seasonal Affective Disorder Market

The global seasonal affective disorder market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of seasonal affective disorder market for global, Europe, North America, Asia Pacific and South America.

Browse Detailed of TOC, Inquiry and Analyst call on Global Seasonal Affective Disorder Market Report Visit @:


Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *